The effectiveness of individualized homoeopathic treatment on chronic migraine associated with stress and anxiety using MIDAS scale : an open label, prospective, clinical study

This clinical study will evaluate the effectiveness of individualized homoeopathic treatment in individuals diagnosed with chronic migraine (ICD-11 code: 8A80.2) and emotional symptoms such as anxiety and depression. The study will span 1 year and 6 months, with monthly follow-ups. Evaluations will be conducted at baseline, 3rd month, and 6th month using standardized tools: MIDAS (Migraine Disability Assessment), PSS (Perceived Stress Scale), and BAI (Beck Anxiety Inventory). Participants will be selected based on defined inclusion and exclusion criteria, and informed consent will be obtained prior to enrollment.